PULMATRIX, INC. Cash and Restricted Cash
PULMATRIX, INC. (PULM) had Cash and Restricted Cash of $42.31 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2022-11-10
- 2022-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42.31M.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $44.53M.
- 2022-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $49.16M.
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $55.47M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2022-09-30 | $42.31M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $44.53M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $49.16M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $55.47M 10-K · filed 2022-03-29 | |
| 2021-09-30 | $53.70M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $57.11M 10-Q · filed 2022-08-10 | |
| 2021-03-31 | $63.65M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $31.86M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $34.71M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $27.46M 10-Q · filed 2021-08-10 | |
| 2020-03-31 | $24.61M 10-Q · filed 2021-05-11 | |
| 2019-12-31 | $23.64M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $28.08M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $32.02M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $2.35M 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $2.77M 10-K · filed 2020-03-26 | $2.56M 10-K · filed 2019-02-19 |
| 2018-09-30 | $4.01M 10-Q · filed 2019-11-01 | $3.81M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $8.54M 10-Q · filed 2019-08-05 | $8.34M 10-Q · filed 2018-08-03 |
| 2018-03-31 | $1.76M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $3.75M 10-K · filed 2020-03-26 | $3.55M 10-Q · filed 2018-08-03 |
| 2017-09-30 | $6.36M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $10.98M 10-Q · filed 2018-08-03 | |
| 2016-12-31 | $4.18M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |